NCODA Welcomes Dr. Lucio N. Gordan to Board of Directors
NCODA is delighted to announce that Lucio N. Gordan, MD, has been appointed to its Board of Directors. Dr. Gordan, who serves as president and managing physician at Florida Cancer Specialists & Research Institute (FCS), is stepping into this role with a wealth of knowledge and a strong commitment to enhancing patient care in oncology.
Dr. Gordan's Commitment to Oncology Care
Known for his dedication to innovation and patient-centered approaches, Dr. Gordan has been pivotal in guiding FCS to emerge as one of the leading treatment and research centers in the nation. His vision aligns seamlessly with NCODA's mission to empower integrated oncology practices and improve patient outcomes.
Expanding Leadership Through Experience
This new board appointment follows Dr. Gordan's impactful five years of service on NCODA's Executive Council. His insights and guidance have been invaluable in advancing NCODA's mission. As a board member, Dr. Gordan will expand his role further, contributing to strategic leadership that is essential for the organization's growth.
Collaborating for Improved Patient Outcomes
Dr. Michael Reff, RPh, MBA, and Founder of NCODA, expressed enthusiasm regarding Dr. Gordan's expanded role: "We are thrilled to have Dr. Gordan on our Board of Directors. His leadership at FCS has made significant strides in patient impact and community oncology. His clinical expertise and commitment to quality care will be instrumental in our ongoing efforts to support oncology practices and enhance patient outcomes globally."
Advancing Cancer Care Accessibility
At Florida Cancer Specialists, Dr. Gordan has driven initiatives to augment patient access to comprehensive cancer care. This includes expanding opportunities for clinical trials and pioneering research programs. These contributions have not only advanced pharmacy integration into oncology practices but also improved patient care—a shared vision between Dr. Gordan and NCODA.
Personal Commitment to NCODA
Dr. Gordan remarked, "I am honored to join the NCODA Board of Directors and contribute to an organization dedicated to advancing oncology patient care. NCODA's commitment to empowering integrated practices ensures patients receive exceptional care while improving the quality of life for those facing cancer. I look forward to contributing to this mission alongside the board."
NCODA's Vision and Future Direction
Dr. Gordan's appointment signifies NCODA's ongoing commitment to partnering with influential leaders in oncology. The organization is focused on fostering innovation and advocating for patient needs. NCODA's goal is to expand access to high-quality, affordable cancer care while equipping oncology practices with essential resources and guidance.
About NCODA
NCODA, a leading non-profit organization in the field of oncology, aims to empower cancer care professionals to achieve positive, patient-centered outcomes through quality standards and best practices. Since its inception in 2015, NCODA has partnered with over 3,000 integrated care sites and supported more than 12,000 professionals globally to enhance cancer care delivery.
Contact Information
For additional information about NCODA, its initiatives, and Dr. Gordan’s appointment, please contact:
Katie Edmiston
NCODA
(813) 843-1629
Frequently Asked Questions
1. Who is Dr. Lucio N. Gordan?
Dr. Lucio N. Gordan is the president and managing physician at Florida Cancer Specialists and has recently been appointed to the Board of Directors of NCODA.
2. What role does NCODA play in oncology care?
NCODA is dedicated to empowering oncology practices through quality standards and integrated care, enhancing patient outcomes in cancer treatment.
3. What initiatives has Dr. Gordan been involved in?
Dr. Gordan has championed initiatives to improve access to comprehensive cancer care, including the expansion of clinical trials and research at FCS.
4. How does NCODA support cancer treatment providers?
NCODA offers education, resources, and advocacy to oncology professionals and practices, ensuring a coordinated approach to patient care.
5. What is the significance of Dr. Gordan's appointment to NCODA?
His appointment enhances NCODA's leadership and commitment to improving patient care in oncology, leveraging his experience to influence future strategies.
